Alnara Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Alnara Pharmaceuticals Ownership

Who owns Alnara Pharmaceuticals?

Alnara Pharmaceuticals is owned by Eli Lilly. It was acquired on July 2, 2010.

Alnara Pharmaceuticals Business Overview

Where is Alnara Pharmaceuticals headquartered?

Alnara Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What sector is Alnara Pharmaceuticals in?

Alnara Pharmaceuticals is a life science company.

When was Alnara Pharmaceuticals founded?

Alnara Pharmaceuticals was founded in 2008.

Life Science M&A Summary in 2010

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.

Join Mergr to view all 138 acquisitions of life science companies in 2010, including 15 acquisitions by private equity firms, and 123 by strategics.

Alnara Pharmaceuticals, Inc.

840 Memorial Drive,
Cambridge, Massachusetts 02139
United States,
(617) 349-3690
www.alnara.com

Alnara Pharmaceuticals, Inc., a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases. Alnara's lead product in development is liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT). Liprotamase is under review by the U.S. Food and Drug Administration for the treatment of exocrine pancreatic insufficiency (EPI). Causes of EPI include cystic fibrosis, chronic pancreatitis, pancreatectomy and other conditions.


 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.